SCHEDULE 13G/A: Coliseum Capital Entities Disclose Significant Passive Stake in Owens & Minor, Inc.

Coliseum Capital Management, LLC and its affiliates have filed an amended Schedule 13G, revealing a combined beneficial ownership of 15.1% in Owens & Minor, Inc.'s common stock as of March 31, 2025.

Summary

• Coliseum Capital Management, LLC (CCM), Coliseum Capital, LLC (CC), Coliseum Capital Partners, L.P. (CCP), Adam Gray, and Christopher Shackelton (collectively, the "Reporting Persons") have filed an Amendment No. 2 to Schedule 13G regarding their beneficial ownership in Owens & Minor, Inc.
• As of March 31, 2025, CCM, Adam Gray, and Christopher Shackelton each beneficially own 11,562,955 shares of Owens & Minor, Inc. common stock, representing 15.1% of the class.
• Coliseum Capital, LLC and Coliseum Capital Partners, L.P. each beneficially own 9,396,222 shares, representing 12.3% of the class.
• The ownership percentages are calculated based on 76,614,139 shares of common stock outstanding as of April 30, 2025, as reported in Owens & Minor's Form 10-Q filed on May 8, 2025.
• All reported shares are held with shared voting and shared dispositive power among the respective reporting persons.
• The Reporting Persons certify that the securities were not acquired and are not held for the purpose of changing or influencing the control of the issuer, except for activities solely in connection with a nomination under Rule 14a-11.

Sentiment

Score: 5

Explanation: The document is a factual disclosure of beneficial ownership, which is neutral in sentiment. It does not contain positive or negative operational or financial news, but rather provides transparency on a significant shareholder's position.

Positives

• The filing indicates a significant, albeit passive, investment by Coliseum Capital, which could be viewed as a vote of confidence in Owens & Minor's long-term prospects by a notable investment firm.
• The disclosure of a substantial institutional stake can sometimes attract other institutional investors, potentially increasing liquidity and stability for the stock.

Negatives

• The filing itself does not contain negative financial or operational information about Owens & Minor, Inc.

Risks

• While the filing states the investment is not for control, the explicit allowance for activities solely in connection with a nomination under Rule 14a-11 suggests a potential for future shareholder activism or engagement regarding board composition, which could introduce uncertainty or management distraction.
• A large concentration of shares held by a single group, even if passive, could lead to significant price volatility if that group decides to liquidate a substantial portion of its holdings.

Future Outlook

This Schedule 13G filing is a disclosure of current beneficial ownership and does not contain any forward-looking statements or guidance regarding Owens & Minor, Inc.'s future financial performance or strategic outlook.

Industry Context

This filing is a standard disclosure for significant passive investments by institutional investors in publicly traded companies. Coliseum Capital Management, LLC, as an investment adviser, manages funds that take substantial positions in companies like Owens & Minor, Inc., a global healthcare solutions company. Such filings provide transparency into major ownership stakes, which can be relevant for market participants assessing a company's shareholder base and potential for investor engagement.

Stakeholder Impact

• Shareholders: Provides transparency regarding a significant institutional investor's stake, which could influence perceptions of the company's stability and investor confidence. The potential for director nominations, while not a control intent, indicates a level of active interest in governance.
• Management: Awareness of a large, potentially active, shareholder group may influence strategic decisions or communication efforts, particularly given the allowance for director nominations.

Key Dates

Keywords

Owens & Minor, Coliseum Capital Management, Schedule 13G, Beneficial Ownership, Common Stock, SEC Filing, Institutional Investor, Shareholder Stake, Investment Firm, Healthcare Distribution